Pharma Journalist -

ADVANZ PHARMA Corp. Limited, a UK headquartered global pharmaceutical company with a strategic focus on speciality, hospital and rare disease medicines in Europe, Canada, and Australia,…
Read More...

This ground-breaking event is tailor-made for scientists, analytical and research and development professionals within the pharmaceutical, biopharmaceuticals, natural products,…
Read More...

Regeneron Pharmaceuticals, Inc. and Intellia Therapeutics, Inc. announced an expanded research collaboration to develop additional in vivo CRISPR-based gene editing therapies focused on…
Read More...

Eli Lilly and Company and POINT Biopharma Global, Inc. announced a definitive agreement for Lilly to acquire POINT, a radiopharmaceutical company with a pipeline of clinical and…
Read More...

Karuna Therapeutics, Inc., a biopharmaceutical company driven to discover, develop, and deliver transformative medicines for people living with psychiatric and neurological conditions,…
Read More...

Maryland-based biotech company Deka Biosciences announced that it has successfully closed a USD $20 Million Series B2 financing with a syndicate of life science investors led by MPM…
Read More...

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a partnership with The Structural Genomics Consortium ("SGC"), a public-private partnership that…
Read More...

Amicus Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Pombiliti™ (cipaglucosidase alfa-atga) + Opfolda™ (miglustat) 65mg capsules. This…
Read More...

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for odronextamab to…
Read More...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, is the first CTDMO (contract testing, development and manufacturing organization) to offer…
Read More...